Zepp Health (NYSE:ZEPP – Get Free Report) and KB Home (NYSE:KBH – Get Free Report) are both consumer discretionary companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk and valuation.
Valuation & Earnings
This table compares Zepp Health and KB Home”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Zepp Health | $258.90 million | 0.27 | -$40.07 million | ($2.52) | -1.86 |
| KB Home | $6.24 billion | 0.58 | $428.79 million | $2.87 | 20.43 |
Profitability
This table compares Zepp Health and KB Home’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Zepp Health | -14.70% | -15.64% | -6.03% |
| KB Home | 4.94% | 7.67% | 4.37% |
Institutional & Insider Ownership
52.6% of Zepp Health shares are held by institutional investors. Comparatively, 96.1% of KB Home shares are held by institutional investors. 36.0% of Zepp Health shares are held by insiders. Comparatively, 4.7% of KB Home shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for Zepp Health and KB Home, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Zepp Health | 1 | 0 | 1 | 0 | 2.00 |
| KB Home | 1 | 11 | 4 | 0 | 2.19 |
Zepp Health currently has a consensus target price of $56.28, suggesting a potential upside of 1,102.82%. KB Home has a consensus target price of $60.17, suggesting a potential upside of 2.64%. Given Zepp Health’s higher possible upside, analysts clearly believe Zepp Health is more favorable than KB Home.
Volatility and Risk
Zepp Health has a beta of 1.86, indicating that its share price is 86% more volatile than the S&P 500. Comparatively, KB Home has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500.
Summary
KB Home beats Zepp Health on 11 of the 14 factors compared between the two stocks.
About Zepp Health
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. The company offers smart bands, watches, modules, and scales; and associated accessories, smart hearable products, sportswear, home fitness equipment, home appliances, and smart watch accessories. It also provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.
About KB Home
KB Home operates as a homebuilding company in the United States. It operates through four segments: West Coast, Southwest, Central, and Southeast. It builds and sells various homes, including attached and detached single-family residential homes, townhomes, and condominiums primarily for first-time, first move-up, second move-up, and active adult homebuyers. The company also provides financial services, such as insurance products and title services, as well as mortgage banking services, including residential consumer mortgage loans to homebuyers. It has operations in Arizona, California, Colorado, Florida, Idaho, Nevada, North Carolina, Texas, and Washington. The company was formerly known as Kaufman and Broad Home Corporation and changed its name to KB Home in January 2001. KB Home was founded in 1957 and is based in Los Angeles, California.
Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.
